Skip to main content
$4.88 $0.04 (0.8%)

04:00 PM EST on 03/01/24

LianBio (NASDAQ:LIAN)

CAPS Rating: No stars

Lianbio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries.

Current Price $4.88 Mkt Cap $523.0M
Open $4.85 P/E Ratio -5.98
Prev. Close $4.88 Div. (Yield) $0.00 (0.0%)
Daily Range $4.84 - $4.88 Volume 286,558
52-Wk Range $1.33 - $4.88 Avg. Daily Vol. 530,330

Caps

How do you think NASDAQ:LIAN will perform against the market?

Add Stock to CAPS Watchlist

All Players

2 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:LIAN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:LIAN Summary

  • Sector:
  • Industry:
  • Tags:

Fools bullish on NASDAQ:LIAN are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about LIAN.

No one has written a Pitch for LIAN stock yet. Tell us why you think LIAN will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in LIAN.

Score Leader

ababrmon

ababrmon (34.25) Score: +237.73

The Score Leader is the player with the highest score across all their picks in LIAN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ababrmon 34.25 5/5/2022 Outperform 5Y $1.35 +261.57% +23.84% +237.73 0 Comment
shonny2 44.80 6/1/2022 Outperform 5Y $1.44 +237.37% +23.53% +213.85 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LIAN.